| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/18/2001 | US6331631 Reacting 4-piperidinocarboxamide and 1-bromobutane, reduction with lithium aluminum hydride using toluene as solvent |
| 12/18/2001 | US6331630 Dimeric arylisoquinoline alkaloids and derivatives thereof |
| 12/18/2001 | US6331623 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 12/18/2001 | US6331622 Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein |
| 12/18/2001 | US6331613 Nucleotide sequences coding protein associated with cytokine activity; for use in treating allergies, autoimmune diseases and acquired immune deficiency syndrome; for preventing cell differentiation; for activating tissue regeneration |
| 12/18/2001 | US6331571 Methods of treating and preventing attention deficit disorders |
| 12/18/2001 | US6331570 Active enantiomer of RARγ-specific agonist |
| 12/18/2001 | US6331568 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
| 12/18/2001 | US6331566 Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use |
| 12/18/2001 | US6331565 Inhibit virus dna replication and antigen expression |
| 12/18/2001 | US6331564 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease |
| 12/18/2001 | US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors |
| 12/18/2001 | US6331561 Use of substituted amino-methyl-chromans for the prevention of neuronal degeneration and for the promotion of neuronal regeneration |
| 12/18/2001 | US6331560 Tumor necrosis factor alpha (TNF-α) inhibiting pharmaceuticals |
| 12/18/2001 | US6331559 Lipoic acid derivatives and their use in treatment of disease |
| 12/18/2001 | US6331557 Use of divalent cations for inhibiting erythrocyte dehydration in vivo |
| 12/18/2001 | US6331556 Benzofuran-4-carboxylic acid amide derivatives used as phosphodiesterase iv or tumor necrosis factor inhibitors |
| 12/18/2001 | US6331555 Evaluating susceptibility of cancer to compounds which inhibit platelet derived growth factor receptor activity |
| 12/18/2001 | US6331554 Antipicornaviral compounds, compositions containing them, and methods for their use |
| 12/18/2001 | US6331553 Inhibitors of nitric oxide synthase; treating cerebrovascular diseases |
| 12/18/2001 | US6331552 Therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorders |
| 12/18/2001 | US6331551 Cosmetic formulation for treating skin disorder caused by microbial infection, comprising sclareol-like or sclareolide-like compound in cosmetically acceptable carrier |
| 12/18/2001 | US6331550 Methods of use of quinolone compounds against anaerobic pathogenic bacteria |
| 12/18/2001 | US6331549 Treatment of urinary stress incontinence, venous insufficiency, venous ulcers, migraine or gastrointestinal disorders |
| 12/18/2001 | US6331546 Use of 2-amino-3,4-dihydroquinazolines for the production of a medicament for the treatment or prophylaxis of illnesses caused by ischemic conditions |
| 12/18/2001 | US6331544 Treating positive and negative symptoms of schizophrenia and other psychoses |
| 12/18/2001 | US6331543 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 12/18/2001 | US6331542 Protease inhibitors |
| 12/18/2001 | US6331540 Enhancing stability of aqueous pharmaceutical composition containing xanthan gum and fluoroquinolone antibiotic drug by adding water-soluble calcium salt |
| 12/18/2001 | US6331539 Sulfonamide and sulfamide substituted imidazoquinolines |
| 12/18/2001 | US6331537 Treating neurological disorders in animals |
| 12/18/2001 | US6331536 Administering to patient in need thereof effective amount of serotonin receptor antagonist to prevent or ameliorate sleep-related breathing disorder |
| 12/18/2001 | US6331535 Retinyl carbonate derivatives, preparation process and uses |
| 12/18/2001 | US6331534 Steroids as neurochemical stimulators of the VNO to alleviate pain |
| 12/18/2001 | US6331533 Administering to cat therapeutically effective amount of bisphosphonate or pharmaceutically acceptable salt thereof to treat feline dental resorptive lesions |
| 12/18/2001 | US6331532 Mitochondrially targeted antioxidants |
| 12/18/2001 | US6331529 Treatment of dry eye disease, vaginal dryness, rhinosinusitis and dry mouth |
| 12/18/2001 | US6331528 Expressing thymidine kinase gene in cell and administering9-(1*,2*-bis(hydroxymethyl)cyclopropan-1*-yl)meth ylguanine |
| 12/18/2001 | US6331527 Promoter smooth muscle cell expression |
| 12/18/2001 | US6331526 Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides |
| 12/18/2001 | US6331525 Targeted delivery of genes encoding interferon |
| 12/18/2001 | US6331522 Antibacterial and antifungal peptide |
| 12/18/2001 | US6331425 Nucleotide sequences coding enzymatic polypeptide; for use in the diagnosis and treatment of cancer, meningitis and urogenital disorders; for sequencing preferential oligosaccharides |
| 12/18/2001 | US6331417 Determine amount of target nucleotide sequences in sample; mix sample with control sequences, incubate with nucleotide sequences, perform nucleotide sequence amplification, calculate amount of control and target sequences |
| 12/18/2001 | US6331411 TopA |
| 12/18/2001 | US6331410 Polynucleotides encoding a novel pyrR homolog |
| 12/18/2001 | US6331398 Nucleic acid ligands |
| 12/18/2001 | US6331317 Pumping active agent and polymer through static mixer forming an emulsion, flowing through a manifold into quench liquid forming microparticles |
| 12/18/2001 | US6331316 2',3'-dideoxyinosine and methacrylic acid copolymer core; resistance to disintegration; drug release properties |
| 12/18/2001 | US6331315 Powder compositions of unilamellar liposomes |
| 12/18/2001 | US6331314 Amphiphilic substances is pumped to a high-pressure homogenizer with nozzle of hard ceramic plate, liposome dispersion |
| 12/18/2001 | US6331313 Controlled-release biocompatible ocular drug delivery implant devices and methods |
| 12/18/2001 | US6331298 Wound healing and treatment of fibrotic disorders |
| 12/18/2001 | US6331296 Food additives which affect conformationally altered proteins |
| 12/18/2001 | US6331293 Dimer amidopropyl dimethyl phospholipids as barrier compounds |
| 12/18/2001 | US6331286 Methods for high energy phototherapeutics |
| 12/18/2001 | CA2235967C Diarylethylene metallocene derivatives, their processes of preparation and pharmaceutical compositions containing said derivatives |
| 12/18/2001 | CA2221448C Antisense oligonucleotide modulation of raf gene expression |
| 12/18/2001 | CA2220182C Method of altering the contents of eggs |
| 12/18/2001 | CA2213815C Pyrrolidinyl hydroxamic acid compounds and their production process |
| 12/18/2001 | CA2204290C Benzimidazole derivatives, their production and use |
| 12/18/2001 | CA2202484C Use of indole derivatives for the treatment of various diseases |
| 12/18/2001 | CA2192665C Methods of lightening hyperpigmented regions in mammalian skin |
| 12/18/2001 | CA2178161C Indole derivatives |
| 12/18/2001 | CA2166470C Pharmacologically active enantiomers |
| 12/18/2001 | CA2160725C Process for the preparation of a tetrazole derivative in two crystalline forms and novel crystalline form of said derivative |
| 12/18/2001 | CA2085589C Benzoquinazoline compounds |
| 12/18/2001 | CA2083143C Process for the preparation of 7.alpha.-alkoxycephem derivatives |
| 12/18/2001 | CA2082923C Sulfonyl compounds |
| 12/18/2001 | CA2074215C Improved oral dosing formulations of dideoxy purine nucleosides |
| 12/18/2001 | CA2063610C Method for the treatment of aging or photo-damaged skin |
| 12/18/2001 | CA2057917C New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof |
| 12/18/2001 | CA2031897C Carbamoyl derivatives |
| 12/15/2001 | CA2311708A1 Method of treating depression using l-threo-methylphenidate |
| 12/13/2001 | WO2001094613A2 Methods and compounds for influencing beta3 integrin-dependent intracellular processes |
| 12/13/2001 | WO2001094612A2 Method for identifying medically valuable active substances |
| 12/13/2001 | WO2001094550A2 Identification and use of molecular markers indicating cellular reprogramming |
| 12/13/2001 | WO2001094410A1 Insulin regulated substance (irs-2) induced by pioglitazone, assay and use thereof |
| 12/13/2001 | WO2001094369A2 Heterocycle derivatives and methods of use for treating anthrax infection |
| 12/13/2001 | WO2001094368A1 2-aminocarbonyl-9h-purine derivatives |
| 12/13/2001 | WO2001094367A1 Malto-oligosaccharide derivatives and use thereof |
| 12/13/2001 | WO2001094358A1 Organophosphorous hydroxamic acid derivatives used as herbicides |
| 12/13/2001 | WO2001094357A1 Antitumoral compounds |
| 12/13/2001 | WO2001094353A1 Thiophene derivatives useful as anticancer agents |
| 12/13/2001 | WO2001094351A1 Caspase inhibitors and uses thereof |
| 12/13/2001 | WO2001094350A1 6-phenylpyrrolopyrimidinedione derivatives |
| 12/13/2001 | WO2001094347A1 Tetracyclic diketopiperazine compounds as pdev inhibitors |
| 12/13/2001 | WO2001094346A1 1,3,8-TRIAZA-SPIRO'4,5!DECAN-4-ONE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS |
| 12/13/2001 | WO2001094345A2 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 12/13/2001 | WO2001094344A1 Thiazolidinedione salt for treatment of diabetes mellitus |
| 12/13/2001 | WO2001094343A1 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical |
| 12/13/2001 | WO2001094342A1 Novel oxazolidinone derivatives and a process for the preparation thereof |
| 12/13/2001 | WO2001094341A1 Quinazoline derivatives for the treatment of tumours |
| 12/13/2001 | WO2001094338A1 Admantane derivatives |
| 12/13/2001 | WO2001094335A2 Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor |
| 12/13/2001 | WO2001094333A2 Process for the preparation of benzoyl substituted bicyclic compounds and chiral benzopyran derivatives |
| 12/13/2001 | WO2001094325A1 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 12/13/2001 | WO2001094321A1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists |
| 12/13/2001 | WO2001094319A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors |
| 12/13/2001 | WO2001094312A2 Indolinone derivatives as protein kinase/phosphatase inhibitors |